|
Clinical activity and safety of cobimetinib (cobi) and atezolizumab in colorectal cancer (CRC). |
|
|
No Relationships to Disclose |
|
|
|
Research Funding - Bayer (Inst); Merck Serono (Inst); Roche/Genentech (Inst) |
|
|
Consulting or Advisory Role - Bayer; Otsuka |
Research Funding - Bayer; Genentech/Roche; Kyowa Hakko Kirin |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
|
|
Consulting or Advisory Role - AstraZeneca; Baxalta; Lilly; Merck; Novartis |
Research Funding - Mogam Biotechnology Research Institue (Inst) |
|
|
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses - Novartis |
|
|
Consulting or Advisory Role - Alexion Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Genentech; Inovio Pharmaceuticals; Merck; Third Rock Ventures |
Research Funding - Bristol-Myers Squibb |
|
|
Honoraria - Amgen; Bayer; Bionomics; Circadian Technologies; Merck Serono; Novartis |
Research Funding - GlaxoSmithKline (Inst); Novartis (Inst); Roche/Genentech (Inst) |
|
|
No Relationships to Disclose |
|
|
Honoraria - AstraZeneca; Bristol-Myers Squibb |
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb (Inst); Eisai; Merck Sharp & Dohme (Inst); Pfizer (Inst); Roche/Genentech (Inst) |
Research Funding - Pfizer (Inst) |
Patents, Royalties, Other Intellectual Property - Royalties from Veristrat (Biodesix) |
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Merck; Roche |
|
|
Honoraria - Amgen; Astellas Pharma; Emergent BioSolutions; Merck; Novartis |
Consulting or Advisory Role - Amgen; Emergent BioSolutions; Merck; Novartis |
Research Funding - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); Lilly/ImClone (Inst); Merck (Inst); NCCN/Glaxo-Smith Kline (Inst); Novartis (Inst); Pfizer (Inst); VentiRx (Inst) |
Travel, Accommodations, Expenses - Merck; Novartis |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Genentech; Merck; Novartis |
Research Funding - Adaptimmune; AstraZeneca; Bristol-Myers Squibb; Genentech; Merck; Novartis |
Travel, Accommodations, Expenses - Affymetrix |
|
|
Stock and Other Ownership Interests - Clovis Oncology; Loxo |
Consulting or Advisory Role - Amgen; Genentech; GlaxoSmithKline; Lilly; Merck; Momenta Pharmaceuticals; Novartis; Oncoceutics; Sanofi; Viralytics |
Research Funding - Novartis; Sanofi |
Travel, Accommodations, Expenses - GlaxoSmithKline; Sanofi |
|
|
No Relationships to Disclose |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
Patents, Royalties, Other Intellectual Property - Novartis |
|
|
No Relationships to Disclose |
|
|
Employment - Roche/Genentech |
Stock and Other Ownership Interests - Roche/Genentech |
|
|
No Relationships to Disclose |